These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26669801)

  • 21. Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users.
    Shanmughapriya S; Sornakumari H; Lency A; Kavitha S; Natarajaseenivasan K
    Med Mycol; 2014 Nov; 52(8):853-61. PubMed ID: 25202127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.
    You J; Du L; King JB; Hall BE; Cichewicz RH
    ACS Chem Biol; 2013 Apr; 8(4):840-8. PubMed ID: 23387427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation.
    Prażyńska M; Gospodarek E
    Mycopathologia; 2014 Feb; 177(1-2):19-27. PubMed ID: 24436013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-1,3-glucanase disrupts biofilm formation and increases antifungal susceptibility of Candida albicans DAY185.
    Tan Y; Ma S; Leonhard M; Moser D; Schneider-Stickler B
    Int J Biol Macromol; 2018 Mar; 108():942-946. PubMed ID: 29104052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.
    Troskie AM; Rautenbach M; Delattin N; Vosloo JA; Dathe M; Cammue BP; Thevissen K
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3697-707. PubMed ID: 24752256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm.
    Czuban M; Wulsten D; Wang L; Di Luca M; Trampuz A
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110406. PubMed ID: 31401462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-biofilm activity of a sophorolipid-amphotericin B niosomal formulation against Candida albicans.
    Haque F; Sajid M; Cameotra SS; Battacharyya MS
    Biofouling; 2017 Oct; 33(9):768-779. PubMed ID: 28946803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
    do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I
    Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
    Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
    [No Abstract]   [Full Text] [Related]  

  • 30. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy.
    Jakab Á; Emri T; Sipos L; Kiss Á; Kovács R; Dombrádi V; Kemény-Beke Á; Balla J; Majoros L; Pócsi I
    J Basic Microbiol; 2015 Aug; 55(8):973-81. PubMed ID: 25707543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-biofilm properties of eucalyptol in combination with antifungals against Candida albicans isolates in patients with hematological malignancy.
    Keymaram M; Falahati M; Farahyar S; Lotfali E; Abolghasemi S; Mahmoudi S; Sadeghi F; Khalandi H; Ghasemi R; Shamsaei S; Raiesi O
    Arch Microbiol; 2022 May; 204(6):295. PubMed ID: 35508567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
    De Cremer K; Lanckacker E; Cools TL; Bax M; De Brucker K; Cos P; Cammue BP; Thevissen K
    Antimicrob Agents Chemother; 2015 Jan; 59(1):421-6. PubMed ID: 25367916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-biofilm activity of a semi-synthetic molecule obtained from resveratrol against Candida albicans biofilm.
    Juin C; Perrin F; Puy T; Bernard C; Mollichella ML; Girardot M; Costa D; Guillard J; Imbert C
    Med Mycol; 2020 Jun; 58(4):530-542. PubMed ID: 31504755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of the
    Guirao-Abad JP; Pujante V; Sánchez-Fresneda R; Yagüe G; Argüelles JC
    J Med Microbiol; 2019 Oct; 68(10):1479-1488. PubMed ID: 31380734
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1.
    Ramachandran R; Shrivastava M; Narayanan NN; Thakur RL; Chakrabarti A; Roy U
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the potential of four cathelicidins for the management of mouse candidiasis and Candida albicans biofilms.
    Yu H; Liu X; Wang C; Qiao X; Wu S; Wang H; Feng L; Wang Y
    Biochimie; 2016 Feb; 121():268-77. PubMed ID: 26656137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Not Available].
    Nuryastuti T; Setiawati S; Ngatidjan N; Mustofa M; Jumina J; Fitriastuti D; Mardjan MID
    J Mycol Med; 2018 Jun; 28(2):367-373. PubMed ID: 29510961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.
    Zhou Y; Wang G; Li Y; Liu Y; Song Y; Zheng W; Zhang N; Hu X; Yan S; Jia J
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3250-60. PubMed ID: 22391539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.